April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Michael Duruisseaux: First effective targeted therapy in NRG1-fusion + solid tumors
Feb 9, 2025, 15:33

Michael Duruisseaux: First effective targeted therapy in NRG1-fusion + solid tumors

Michael Duruisseaux,  Physician-Scientist in the Onco-Pharmacology team at the Lyon Cancer Research Center, shared an article by Alison M. Schram, et al. on X:

Hot of the press NEJM: Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer | New England Journal of Medicine.

First effective targeted therapy in NRG1-fusion + solid tumors.

Very proud to collaborate to this study.”

Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer.

Authors: Alison M. Schram, et al.

Michael Duruisseaux: First effective targeted therapy in NRG1-fusion + solid tumors